Polyoxometalates (POMs) electrostatically bind to silica nanoparticles coated with cationic aluminum oxide "(Si/AlO2)n+" to form a new type of material (the anionic POMs replace Cl- counterions associated with the cationic surface sites). Association of a new approximately D3h POM of formula [(FeIII(OH2)2)3(A-alpha-PW9O34)2]9- (1) with the cationic nanoparticles (to form "K81/(Si/AlO2)") was studied in detail. Elemental analysis, particle sizes from both laser light scattering and TEM before and after association of 1, the size of 1 from X-ray crystallography, and other methods provide mutually consistent data that indicate about 58 K8[(FeIII(OH2)2)3(A-alpha-PW9O34)2]- monoanions associate with the average nanoparticle (diameter of the K81/(Si/AlO2) product = approximately 17 nm). While heterogeneity of the cationic sites and roughness of the (Si/AlO2)n+ surfaces make the associated POMs structurally nonuniform, the equivalent of approximately 1 monolayer of 1 is present in K81/(Si/AlO2). Remarkably, while 1, the precursor (Si/AlO2)n+, and the components of 1, each alone, are inactive as catalysts for O2/air-based oxidation of sulfides or aldehydes in solution, K81/(Si/AlO2) is an active catalyst for both reactions (facile reaction with air at low temperature).
No takes yet. Share an insight, caveat, or question.
Okun et al. (2003) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: